RHÖN-KLINIKUM Overview

  • Year Founded
  • 1973

Year Founded

  • Status
  • Public

  • Employees
  • 18,507

Employees

  • Stock Symbol
  • RHK

Stock Symbol

  • Investments
  • 41

  • Share Price
  • $14.73
  • (As of Tuesday Closing)

RHÖN-KLINIKUM General Information

Description

Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Salzburger Leite 1
  • 97616 Bad Neustadt an der Saale
  • Germany
+49 09771
Primary Industry
Hospitals/Inpatient Services
Other Industries
Clinics/Outpatient Services
Stock Exchange
ETR
Vertical(s)
Corporate Office
  • Salzburger Leite 1
  • 97616 Bad Neustadt an der Saale
  • Germany
+49 09771

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RHÖN-KLINIKUM Stock Performance

As of 11-Feb-2025, RHÖN-KLINIKUM’s stock price is $14.73. Its current market cap is $986M with 66.9M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.73 $14.75 $10.23 - $16.61 $986M 66.9M 2.45K $0.73

RHÖN-KLINIKUM Financials Summary

As of 30-Sep-2024, RHÖN-KLINIKUM has a trailing 12-month revenue of $1.68B.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 752,931 461,043 919,593 906,903
Revenue 1,676,637 1,584,136 1,520,419 1,657,594
EBITDA 120,390 115,131 111,458 118,892
Net Income 48,655 41,889 26,436 33,453
Total Assets 2,056,759 1,957,137 1,828,378 1,885,823
Total Debt 179,553 165,699 169,653 180,929
Public Fundamental Data provided by Morningstar, Inc. disclaimer

RHÖN-KLINIKUM Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RHÖN-KLINIKUM‘s full profile, request access.

Request a free trial

RHÖN-KLINIKUM Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pul
Hospitals/Inpatient Services
Bad Neustadt an der Saale, Germany
18,507 As of 2024

Munich, Germany
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RHÖN-KLINIKUM Competitors (4)

One of RHÖN-KLINIKUM’s 4 competitors is Schön Klinik, a Private Equity-Backed company based in Munich, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Schön Klinik Private Equity-Backed Munich, Germany
Ramsay Health Care UK Formerly PE-Backed London, United Kingdom
Schoen Clinic UK Corporate Backed or Acquired London, United Kingdom
Isar Kliniken Corporate Backed or Acquired Munich, Germany
To view RHÖN-KLINIKUM’s complete competitors history, request access »

RHÖN-KLINIKUM Patents

RHÖN-KLINIKUM Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102004041063-A1 Irradiation device with retractable door Inactive 19-Aug-2004
EP-1789135-A1 Irradiation apparatus comprising a retractable door Inactive 19-Aug-2004
ES-2331370-T3 Irradiation device Active 09-Jun-2004
DE-102004029026-A1 Irradiation device Inactive 09-Jun-2004
EP-1761309-A1 Irradiation apparatus Active 09-Jun-2004 A61N5/10
To view RHÖN-KLINIKUM’s complete patent history, request access »

RHÖN-KLINIKUM Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RHÖN-KLINIKUM Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RHÖN-KLINIKUM‘s full profile, request access.

Request a free trial

RHÖN-KLINIKUM Investments & Acquisitions (41)

RHÖN-KLINIKUM’s most recent deal was a Later Stage VC with Clew (Decision/Risk Analysis) for . The deal was made on 15-Jan-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Clew (Decision/Risk Analysis) 15-Jan-2020 Later Stage VC Decision/Risk Analysis
Medgate Deutschland 07-Nov-2019 Joint Venture Other Healthcare Services
Tiplu 13-Feb-2019 Corporate Enterprise Systems (Healthcare)
Marburger Ionenstrahl-Therapiezentrum 01-Jan-2019 Merger/Acquisition Clinics/Outpatient Services
Herz- Und Gefäss-Klinik 01-Aug-2018 Merger/Acquisition Hospitals/Inpatient Services
You’re viewing 5 of 41 investments and acquisitions. Get the full list »

RHÖN-KLINIKUM ESG

Risk Overview

Risk Rating

Updated August, 08, 2023

34.87 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,048

Rank

Percentile

Healthcare

Industry

of 635

Rank

Percentile

Medical Facilities

Subindustry

of 142

Rank

Percentile

To view RHÖN-KLINIKUM’s complete esg history, request access »

RHÖN-KLINIKUM Exits (1)

RHÖN-KLINIKUM’s most recent exit was on 17-Jan-2012 from Dr.-Horst-Schmidt-Kliniken. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Dr.-Horst-Schmidt-Kliniken 17-Jan-2012 Completed
To view RHÖN-KLINIKUM’s complete exits history, request access »

Affiliates

Subsidiaries (12)

Name Industry Location Year Founded
Rhön-Innovations Bad Neustadt An Der Saale, Germany 2016
Marburger Ionenstrahl-Therapiezentrum Marburg, Germany 2014
University Hospital Gießen and Marburg Giessen, Germany 2005
Mvz Management Gmbh Süd Pforzheim, Germany 2004
Helios Klinikum Pforzheim Pforzheim, Germany 2003
You’re viewing 5 of 12 affiliates. Get the full list.  »

RHÖN-KLINIKUM FAQs

  • When was RHÖN-KLINIKUM founded?

    RHÖN-KLINIKUM was founded in 1973.

  • Where is RHÖN-KLINIKUM headquartered?

    RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.

  • What is the size of RHÖN-KLINIKUM?

    RHÖN-KLINIKUM has 18,507 total employees.

  • What industry is RHÖN-KLINIKUM in?

    RHÖN-KLINIKUM’s primary industry is Hospitals/Inpatient Services.

  • Is RHÖN-KLINIKUM a private or public company?

    RHÖN-KLINIKUM is a Public company.

  • What is RHÖN-KLINIKUM’s stock symbol?

    The ticker symbol for RHÖN-KLINIKUM is RHK.

  • What is the current stock price of RHÖN-KLINIKUM?

    As of 11-Feb-2025 the stock price of RHÖN-KLINIKUM is $14.73.

  • What is the current market cap of RHÖN-KLINIKUM?

    The current market capitalization of RHÖN-KLINIKUM is $986M.

  • What is RHÖN-KLINIKUM’s current revenue?

    The trailing twelve month revenue for RHÖN-KLINIKUM is $1.68B.

  • Who are RHÖN-KLINIKUM’s competitors?

    Schön Klinik, Ramsay Health Care UK, Schoen Clinic UK, and Isar Kliniken are competitors of RHÖN-KLINIKUM.

  • What is RHÖN-KLINIKUM’s annual earnings per share (EPS)?

    RHÖN-KLINIKUM’s EPS for 12 months was $0.73.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »